Yongjiang Yu (Haojie Chen, Hao-Jie Chen)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Hang Qian, Yun-Tian Shi, Xu-Jun Sheng, Hai-Hong Liao, Yongjiang Yu, Bo-Wen Shi, Yong-Jiang Yu
Evaluating the Role of Morphological Parameters in the Prostate Transition Zone in PHI-Based Predictive Models for Detecting Gray Zone Prostate Cancer. Clinical Medicine Insights. Oncology 17 (2023)
Haojie Chen, Bowen Shi, Yanyuan Wu, Yuhang Qian, Jiatong Zhou, Xi Zhang, Jie Ding, Yongjiang Yu
The modified prostate health index (PHI) outperforms PHI density in the detection of clinical prostate cancer within the PSA grey zone. International urology and nephrology 54 (4) (2022)
Jiatong Zhou, Yongjiang Yu, Yanyuan Wu, Bowen Shi, Jie Ding, Jun Qi
Plasma IL-6 and TNF-α levels correlate significantly with grading changes in localized prostate cancer. The Prostate 82 (5) (2022)
Yongjiang Yu, Jia Luo, Shaojun Chen, Bowen Shi, Xiaocui Zheng, Haiying Ji, Xiaoqian Zhang, Yujia Yin, Kun Du, Jie Ding, Yongjiang Yu
Non-drug efflux function of ABCC5 promotes enzalutamide resistance in castration-resistant prostate cancer via upregulation of P65/AR-V7. Cell death discovery 8 (1) (2022)
Bowen Shi, Yanyuan Wu, Yongjiang Yu, Jie Ding, Jun Qi
Understanding of mouse and human bladder at single-cell resolution: integrated analysis of trajectory and cell-cell interactive networks based on multiple scRNA-seq datasets. Cell proliferation 55 (1) (2021)